Clinical Isolate of Candida tropicalis from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of Ganoderma lucidum.

医学微生物学(英文) Pub Date : 2025-03-01 Epub Date: 2025-03-05 DOI:10.4236/ojmm.2025.151002
Akamu Ewunkem, Lydia Merrills, Zahirah Williams, Lisa Maness, Jeffery Meixner, Brittany Justice, Uchenna Iloghalu, Vera Williams, Larisa Kiki, Dinesh Singh
{"title":"Clinical Isolate of <i>Candida tropicalis</i> from a Patient in North Carolina: Identification, Whole-Genome Sequence Analysis, and Anticandidal Activity of <i>Ganoderma lucidum</i>.","authors":"Akamu Ewunkem, Lydia Merrills, Zahirah Williams, Lisa Maness, Jeffery Meixner, Brittany Justice, Uchenna Iloghalu, Vera Williams, Larisa Kiki, Dinesh Singh","doi":"10.4236/ojmm.2025.151002","DOIUrl":null,"url":null,"abstract":"<p><p>In North Carolina, candida infections are on the rise and pose a significant threat to human health in clinical settings. In addition, the rise of resistance to antifungal drugs has only heightened this concern. Importantly, misidentification of <i>Candida</i> spp. may result in underdiagnosis, patients getting the wrong treatment and incomplete infection prevention measures. The correct and rapid etiological identification of <i>Candida</i> infections is of paramount importance because it provides adequate therapy, reduces mortality, and controls outbreaks. Hence, this study aimed to identify <i>Candida</i> sp. up to species level of a clinical isolate from an infected patient treated in North Carolina using biochemical and molecular techniques. Due to the emergence of resistance, we explored whole genomic analysis to highlight polymorphisms that can impact candida resistance. Exploration for the effectiveness of bioactive compounds in natural products to treat <i>Candida</i> spp. resistant to present-day drugs could provide promising new treatment options for managing infected patients. Thus, this study also investigated anticandida activity of three solvent extracts of <i>Ganoderma lucidum</i> against the clinical isolate of <i>Candida</i> sp. The findings of this study provided evidence that <i>Candida tropicalis</i> MYA-3404 was the only strain present in the clinical isolate. The whole genome sequencing of <i>C. tropicalis</i> identified mutations in genes that most likely underscore drug resistance. All extracts from <i>G. lucidum</i> significantly (P < 0.05) inhibited the growth of <i>C. tropicalis</i>. Together, this work highlights the enormous potential of biochemical and molecular techniques in identifying clinical isolates of candida to species level and the use of bioactive compounds from extracts of <i>G. lucidum</i> as promising anticandidal agents. Further testing is needed to confirm the phenotypic expression of resistance.</p>","PeriodicalId":58937,"journal":{"name":"医学微生物学(英文)","volume":"15 1","pages":"11-35"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12094522/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"医学微生物学(英文)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4236/ojmm.2025.151002","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/5 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

In North Carolina, candida infections are on the rise and pose a significant threat to human health in clinical settings. In addition, the rise of resistance to antifungal drugs has only heightened this concern. Importantly, misidentification of Candida spp. may result in underdiagnosis, patients getting the wrong treatment and incomplete infection prevention measures. The correct and rapid etiological identification of Candida infections is of paramount importance because it provides adequate therapy, reduces mortality, and controls outbreaks. Hence, this study aimed to identify Candida sp. up to species level of a clinical isolate from an infected patient treated in North Carolina using biochemical and molecular techniques. Due to the emergence of resistance, we explored whole genomic analysis to highlight polymorphisms that can impact candida resistance. Exploration for the effectiveness of bioactive compounds in natural products to treat Candida spp. resistant to present-day drugs could provide promising new treatment options for managing infected patients. Thus, this study also investigated anticandida activity of three solvent extracts of Ganoderma lucidum against the clinical isolate of Candida sp. The findings of this study provided evidence that Candida tropicalis MYA-3404 was the only strain present in the clinical isolate. The whole genome sequencing of C. tropicalis identified mutations in genes that most likely underscore drug resistance. All extracts from G. lucidum significantly (P < 0.05) inhibited the growth of C. tropicalis. Together, this work highlights the enormous potential of biochemical and molecular techniques in identifying clinical isolates of candida to species level and the use of bioactive compounds from extracts of G. lucidum as promising anticandidal agents. Further testing is needed to confirm the phenotypic expression of resistance.

Abstract Image

Abstract Image

Abstract Image

北卡罗莱纳患者临床分离的热带念珠菌:鉴定、全基因组序列分析和灵芝抗念珠菌活性。
在北卡罗来纳州,念珠菌感染呈上升趋势,对临床环境中的人类健康构成重大威胁。此外,抗真菌药物耐药性的上升只会加剧这种担忧。重要的是,假丝酵母菌的错误鉴定可能导致误诊,患者得到错误的治疗和不完整的感染预防措施。正确和快速的病原学鉴定念珠菌感染是至关重要的,因为它提供了充分的治疗,降低死亡率,并控制疫情。因此,本研究旨在利用生化和分子技术鉴定北卡罗莱纳治疗的一名感染患者的临床分离株念珠菌。由于耐药性的出现,我们探索了全基因组分析,以突出可能影响念珠菌耐药性的多态性。探索天然产物中生物活性化合物治疗念珠菌耐药的有效性,可以为管理感染患者提供有希望的新治疗选择。因此,本研究还对三种灵芝溶剂提取物对念珠菌临床分离株的抑菌活性进行了研究,结果表明该临床分离株中只有热带念珠菌MYA-3404。热带镰刀菌的全基因组测序鉴定出最有可能强调耐药性的基因突变。各提取物均显著(P < 0.05)抑制热带棘球蚴的生长。总之,这项工作突出了生物化学和分子技术在鉴别念珠菌临床分离株到物种水平的巨大潜力,以及从灵芝提取物中提取的生物活性化合物作为有前途的抗念珠菌药物的使用。需要进一步的测试来确认抗性的表型表达。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
173
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信